Home
Videos uploaded by user “Proactive Investors Stocktube”
New Age Beverages offers healthy beverages, including Bob Marley-branded product line
 
05:33
New Age Beverages Corp (NASDAQ:NBEV) is targeting consumers looking for healthy beverage options, CEO Brent Willis tells Proactive Investors. The Colorado-based healthy functional beverage company was created in 2016 and is engaged in the development, marketing, sales, and distribution of beverages. Willis says the company owns patents on many of the beverages that it produces. Additionally, the company owns a significant intellectual property portfolio about the future state of the beverage industry. The company offers its products directly, as well as through store delivery distribution systems in the United States and internationally. One product is the Marley line of beverages, created in partnership with Bob Marley’s family. Within the Marley line, there are a range of products including Marley Mate and Mellow Mood. Willis says the company may consider acquisitions going forward and is looking to continue to expand its channels, including e-commerce, military, medical and food service channels.
RNC Minerals unearths possibly biggest ever gold-rich stones in Australia
 
06:40
Mark Selby, President and CEO of RNC Minerals (TSE:RNX) spoke to Proactive London's Andrew Scott after announcing the first specimen slab from the top of the Father's Day Vein discovery area has been recovered at their Beta Hunt Mine in Western Australia. Selby says the slab, weighing around 90kg, is thought to contain approximately 1,000 ounces of gold. RNC reckons the gold-rich stones are among the biggest of their kind ever unearthed in Australia. 'We think we've made one of the great gold discoveries of this decade .. if not this century so far'', Selby says.
Invictus Energy advances Zimbabwe gas-condensate asset amid regulatory reforms
 
05:41
Invictus Energy Ltd (ASX:IVZ) managing director Scott Macmillan speaks to Proactive Investors about the oil and gas exploration company’s Cabora Bassa Project in northern Zimbabwe. “It’s a fantastic asset that we’ve picked up – it was previously explored by Mobil over 30 years ago and it’s been sitting dormant, locked up for the past 25 years. He continues, “the basin is very exciting and the portion of acreage that we’ve picked up contains the Mzarabani prospect. “It’s the largest undrilled seismically-defined structure in onshore Africa that’s got multi-trillion cubic feet potential.”
Fund Manager Marin Katusa shares his thoughts on Mining, Crypto and Cannabis
 
10:00
Best Selling author and fund manager Marin Katusa, from Katusa Research joined us in the Vancouver studio of Proactive Investors to share his thoughts on the state of the mining sector in BC and Canada. Katusa also had thoughts on Cannabis and what the legalization in October 17th in Canada will mean for investing. Katusa also shared something he is very high on and how it could be the next big thing, again.
iAnthus updates investors on activities in six US states
 
07:26
iAnthus Capital Holdings (CSE:IAN, OTCQB:ITHUF) CEO Hadley Ford tells Proactive Investors the cannabis company, which owns, operates and partners with licensed cannabis operations throughout the US, has expanded licensed cannabis cultivation operations, processing and dispensary facilities into six states. Ford updated investors on iAnthus's activities in all six states, and referenced the company's recent groundbreaking on its 39,500 sq. ft. medical cannabis cultivation and processing facility in Warwick, New York. Ford will be presenting to investors at Proactive Investor's CannaJam™ 2018 conference in New York, on September 12.
Namaste Technologies to launch its own version of a cannabis cafe in Toronto
 
07:41
Namaste Technologies Inc (TSXV:N) (OTCMKTS:NXTTF) CEO Sean Dollinger tells Proactive Investors that the cannabis company will be launching a new retail brand called "the Namaste Cafe", establishing its first location in Toronto, early next year. Dollinger says the Namaste Cafe will offer interactive cannabis educational opportunities, in addition to its full line of vaporizers and cannabis accessories, along with its H.E.A.L (healthy eating and living) branded foods products.
Bannerman Resources MD discusses uranium markets, as predictions proven correct
 
13:54
Brandon Munro, managing director of Bannerman Resources Ltd (ASX:BMN; NSX:BMN), catches up with Proactive Investors to give his updated take on global uranium markets. His public predictions about supply side disruption in 20% of the market, made in May, have come true. Prices have risen about 40% in the past six months, and Munro, "[Sees] the sector behaving very optimistically for the next." Bannerman's flagship asset is the wholly-owned Etango Uranium Project in Namibia.
The Green Organic Dutchman Holdings Ltd CEO says CBD is its 'Trojan Horse' into the European market
 
06:06
The Green Organic Dutchman Holdings Ltd (TSX:TGOD, OTCQX:TGODF) CEO Brian Athlaide tells Proactive's Christine Corrado the Canadian cannabis company is pushing into Europe,announcing it is acquiring a Polish CBD company that sells to 13 different countries. Athlaide says CBD is the company's 'Trojan Horse' in allowing it to get into the European market, establish infrastructure, sales and distribution, and will eventually leverage impending legalized medical cannabis to create THC products there. On top of this, Athlaide says the company is building out the 'most advanced cannabis facility in the world' for organic and non-organic in Quebec. Athladie says the build-out of the more than 1.1mln sq ft facility will be completed during the first half of 2019.
Exciting start to 2018 for ImmuPharma with pivotal data 'weeks away'
 
11:48
Tim McCarthy, chairman of ImmuPharma PLC (LON:IMM), caught up with Proactive's Andrew Scott to run through the latest on their Phase III Lupuzor study, results of which are due by the end of this quarter, as well as adding further detail to their ‘follow-up’ study which will allow eligible patients to continue to receive Lupuzor for another six months. The results will be gathered as an ‘extension’ open label study – i.e. patients will know that they’re taking the drug – and will be independent of the original late-stage trial. McCarthy also discusses the strong backing they received from existing and new institutional investors for their £10mln City fundraiser. He says the cash will support future investment in the P140 peptide platform and will also be used to meet working capital requirements.
FAR Ltd turns to The Gambia as SNE oilfield approaches commercialisation milestone
 
07:10
FAR Ltd (ASX:FAR) managing director Cath Norman speaks to Proactive Investors about the oil and gas exploration company’s exciting advancements off the west coast of Africa. The company’s efforts are currently focused on The Gambia, and in particular on the Samo prospect. “Drilling an 800 million barrel prospect is large by any company standards... when you consider that at the moment we have a net 140 million barrels to our name in Senegal, and our market cap’s $500 million, it’s wonderful to think about what our market capitalisation could be after we’ve drilled this Gambian well and have access to maybe another 300 million barrels to FAR’s name. And we’ll have the results of that well by mid to late November at the latest, if we spud on October 1,” says Norman. FAR Ltd’s Senegalese operations are much more advanced, approaching a key milestone on the path to commercialisation. Norman explains, “we’ve got past the three principal hurdles of size, deliverability, and connectivity; so we understand everything about the oilfield now enough to progress to development. We are in a position today where we’ll be submitting the discoveries evaluation report to the government in about two weeks, which is a statement of commerciality, which I know a lot of our shareholders will be very pleased to see. And with that we’ll be progressively releasing some information about the final size for the development, and also the economics. The field will be developed in a phased development approach... we’ll be looking to get approval of our development plan by the end of this year, we’ll take the final investment decision in mid-2019, and then we’ve got an ambition to have first oil in about 2022.”
Glint reintroducing gold as money with launch of 'world first' payments app
 
13:07
Ben Davies, co-founder of Glint, spoke to Proactive as they launched their debit card and app (Glint Pay) which allows consumers to pay for goods and services with gold. The fintech group's teamed up with Lloyds Banking Group to create the app which allows people to load credit onto their card which can then be used to buy part of a physical piece of gold. Glint is regulated by the Financial Conduct Authority (FCA).
FAR Ltd still has high hopes for Gambian blocks with several prospects identified
 
04:42
FAR Ltd (ASX:FAR) managing director Cath Norman speaks to Proactive Investors about the disappointing results of the Samo-1 well offshore The Gambia, explaining that the oil & gas explorer still has high hopes for the acreage and wider area. "The results of the Samo well are going to give us a new data point in the basin that is going to help us better place the next well we drill. We have to keep reminding ourselves that we've got 5 billion barrels of oil in place just 20 kilometres north in the SNE Field, and it's highly unlikely that with such a prolific oil-generating source rock that we're only going to have one working trap. What's encouraging for us is that we did see some hydrocarbon shows in the well," says Norman. Norman also outlines the financial arrangements between Far Ltd and it's JV partners, saying "I think that any company would have paid $1 million to drill an 800 million barrel prospect; and in fact it's exactly what our shareholders want us to do - capture these types of opportunity and get paid to drill them." FAR is looking to drill again elsewhere next year.
How to Invest in Mining: Proactive Investors presents a beginners guide
 
12:43
In the first of a series of “How to” videos, Proactive Investors presents a beginners guide to investing in the mining sector. Featuring Amanda Van Dyke, Women in Mining; Jeremy Wrathall, Investec and Niall Pearson, Hybridan.
InMed Pharmaceuticals disrupting cannabinoid space with biosynthesis technology
 
07:04
InMed Pharmaceuticals Inc (TSX:IN; OTCQX:IMLFF) Chief Business Officer Josh Blacher speaks with Proactive Investor's Christine Corrado about how the biopharma company is changing the game in the cannabinoid space. Blacher says the Vancouver based company, which specializes in developing therapeutics to treat a variety of diseases, is disrupting the space with its cannabinoid biosynthesis technology, which aims to manufacture any of the more than 90 variations of cannabinoids, resulting in products that are bio-identical to the naturally occurring cannabinoids in the cannabis plant.
ContraVir Pharmaceuticals CEO excited to get Hepatitis B drug to patients in new study
 
05:23
ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) CEO James Sapirstein tells Proactive Investors the bio-pharmaceutical company has just announced a new formula of its Hepatitis B drug tenofovir exalidex (TXL) and can start delivering the drug to patients in a dose-range finding study, looking to be in Phase 3 trials sometime in the near future. Sapirstein also updated investors on the New Jersey based company's other Hepatitis B vaccine treatment called CRV-431, saying the FDA approved the company's investigational new drug application (IND).
All eyes on Kimmeridge flow rates as Horse Hill testing gets underway
 
05:34
Independent oil & gas analyst Barney Gray gives his views on the announcement that planned flow testing operations at the Horse Hill-1 well have started. UKOG, which is the largest London-listed stakeholder in the project with a 32% interest, said all key equipment necessary to carry out a 150-day long-term extended flow test campaign at HH-1 is now on site.
Danakali Limited to begin trading on London's Main Market later this month
 
05:23
Seamus Cornelius, executive chairman of Danakali Limited (LON:DNK, ASX:DNK), discusses with Proactive's Andrew Scott their intention to begin trading on the London Stock Exchange Main Market around July 24th. Cornelius says their strategy is to become a leading Sulphate of Potash (SOP) producer through the development of their Colluli Potash Project in Eritrea.
The Green Organic Dutchman executes its spin-off company
 
04:44
The Green Organic Dutchman Holdings Ltd (TSX:TGOD, OTCQX:TGODF) Vice President of Investor Relations Danny Brody updated Proactive's Christine Corrado on the company's plan to complete its spin-off called TGOD Acquisition Corporation. Brody says the company is creating this subsidiary to 'take advantage of international opportunities' and will be traded on the Canadian Securities Exchange. Brody adds to take advantage of this opportunity, investors will need to be shareholders of The Green Organic Dutchman Holdings by mid-December.
Lupuzor could treat a number of diseases, says creator
 
07:45
Sylvaine Muller, creator of ImmuPharma PLC’s (LON:IMM) lead drug candidate Lupuzor, tells Proactive Investors the treatment is “unique” in its treatment for auto-immune disease lupus, as it only targets only the autoimmune system, and not the immune system. But, she adds, “we think that we can open up the indications in which the peptide [molecule] could be effective”. “We have already started some experiments,” Mulller says, which will target a range of diseases including inflammatory, chronic, those related to autoimmunity and those that aren’t - like asthma. “We have first indication that are extremely promising also in these indications,” she adds.
Oragenics is well funded to resume Phase 2 clinical trial for oral mucositis
 
05:00
Oragenics Inc (NYSEAMERICAN:OGEN) CEO Alan Joslyn updates Proactive Investors on the Florida based biotech's advancements in the last six months. Joslyn says the company's lead candidate AG013, which treats oral mucositis, resumed its Phase 2 clinical trial of AG013, following a positive review by an independent Data Safety Monitoring Board, with data expected in the middle of 2019. Joslyn says the trial will soon be expanded into 50 centers in the US and into Europe to complete patient enrollment. Joslyn says the company recently raised $13.8mln to carry the biotech's programs through clinical trials. He says from this point forward most of the work within the company is operational.
Bonterra Resources makes major acquisition that will aid flagship Gladiator Project
 
07:10
Bonterra Resources (CVE: BTR) CEO Nav Dhaliwal dropped by the Vancouver Studios of Proactive Investors to share details about the companies multi-million dollar acquisition and some major news about new targets at their Flagship project Gladiator. Dhaliwal also had a major update about their Larder Lake, Ontario project.
Bulls, Bears & Brokers: Alto Capital's Tony Locantro hopes to lose housing market bet
 
11:16
Tony Locantro, stock market commentator and investment manager at Alto Capital, speaks to Danielle Doporto from Proactive Investors about a bet he has taken up with prominent Australian economist Stephen Koukoulas regarding the Australian housing market. The wager was initially extended to Martin North, principal of Digital Finance Analytics (DFA), following his appearance on a 60 Minutes Australia segment called 'Bricks and Slaughter.' Locantro stands to win A$15,000 from Koukoulas if Sydney or Melbourne or national house prices fall by more than 35% from their peak at any stage before the end of 2021. "I thought that was very attractive terms based on all my research and what I believe in; I can reassure people that there'll be no joy if I get anywhere near this because I think it's going to spell an absolute disaster for Australia," Locantro explains. Tony Tips the stock market as a better place for Aussies to be investing; watch our full video interview to hear which stocks he backs.
Bushveld Minerals 'still very undervalued' as earnings soar
 
19:21
Fortune Mojapelo, Bushveld Mineral Limited’s (LON:BMN) chief executive, believes the miner's first half numbers were good 'by any stretch'. He adds, however, that they were based on an average vanadium price of US$65 per tonne, whereas the current price is US$110 per tonne, which bodes well for the second half. Fundamentals for vanadium are also far stronger going forward than they have been in the past, he reckons. . Phase 3 expansion at the Vametco vanadium mine is commencing in earnest, while the group is also looking for new brownfield assets. A dividend policy should be in place by the end of the year, while a framework to highlight the value in the energy storage business is also planned. “The business is still very undervalued," believes Mojapelo.
'Hot off the press' study says Viemed Healthcare saves a life for every 6 of its patients
 
04:23
Viemed Healthcare (TSXV:VMD) CEO Casey Hoyt tells Proactive Investors the non-invasive ventilation company has 'hot off the press' news relating to a new study done. Hoyt says a KPMG third party study examined patients and a batch of data, and found for every 6 patients, the company saves a life; a 42% reduction in mortality. Hoyt says every patient the company puts on therapy, saves $25,000 per patient, per year. Hoyt says the company is very excited, and study they will move to publish for rest the industry.
Admedus COO encouraged by initial results from Phase II herpes vaccine trial
 
09:06
Admedus Ltd's (ASX:AHZ) chief operating officer Julian Chick talks to Proactive Investors on the interim Herpes Simplex Virus Phase II clinical trial data. The blinded trial provided data from the first 20 patients to receive at least three vaccinations in the randomised, placebo–controlled HSV-2 vaccine Phase II study. Chick says he is “very encouraged” by the first set of results, which shows the study is “going in the right way and we are seeing what we want to see”.
ComplyAdvantage offering a 'next generation' approach to tackling financial crime
 
05:58
ComplyAdvantage founder Charles Delingpole tells Proactive Investors they're a team of compliance and risk experts, engineers and data scientists. He says they're on a mission to help fight financial crime by revolutionising the way companies protect themselves from criminals, terrorists and money launderers.
Canntab Therapeutics calling their extended release tablet a "game changer"
 
08:15
Canntab Therapeutics Ltd. (CSE: PILL) CFO Richard Goldstein joined Proactive Investors Vancouver on Skype, with big news about their technology for a 12 hour extended release pill for medicinal cannabis. Goldstein also provided some details about the companies new facility that will be opening in Cobourg, Ontario and a new deal they have signed with FSD Pharma.
Powerhouse in partnership talks with Toyota Tsusho in Japan
 
11:44
PowerHouse Energy Group PLC (LON:PHE) has been invited to engage in “advanced commercial discussions” over its waste-to-hydrogen DMG technology with Toyota Tsusho – a trading subsidiary of the Japanese conglomerate, Toyota Group. CEO Keith Allaun can barely conceal his excitement as he tells Proactive London about the company-transforming potential of the forthcoming negotiations in early December for PowerHouse in Japan. AIM-quoted PowerHouse said Toyota Tsusho had carried out an “extensive review” of the DMG technology, which converts plastic and tyre residue into syngas that can be converted easily into hydrogen to power buses, lorries or cars using a fuel cell.
MMJ PhytoTech positioned to become 'the Berkshire Hathaway of cannabis’
 
06:24
MMJ Phyto Tech Ltd (ASX:MMJ) chief executive officer Jason Conroy speaks to Proactive Investors about the cannabis investment company’s global portfolio of assets and strategic approach to the cannabis sector. “We invest up to about $5 million per investment across the cannabis value chain and across different stages of investment, either early-stage venture capital, seed capital, through to growth funding and pre-IPO funding. “I’ve been with the company for about 6 months now and my vision for the company is really just to turn it into the Berkshire Hathaway of cannabis. “Our model is built around backing very experienced management teams who understand the space but also understand old-fashioned things like operating cash-flow and how to calculate risk-adjusted returns and manage their business in an appropriate way.”
NetCents disrupting crypto world and soon to have technology in 60 countries
 
06:22
NetCents Technology (CSE:NC) Chief Revenue Officer Jenn Lowther joined Steve Darling from Proactive Investors in Vancouver to provide details about their cryptocurrency payment technology and some key deals the company has signed that will allow them to grow. Lowther also talked about a key part of their system that will allow merchants to settle in their own currency which will save time and money. Lowther also talked about what you can expect from NetCents in 2019.
Emerald Health Therapeutics CFO confirms Canadian supply deals, calls US market 'tantalizing'
 
05:20
Emerald Health Therapeutics Inc (TSX-V:EMH) (OTCQX:EMHTF) CFO Rob Hill tells Proactive's Christine Corrado the Canadian cannabis company is in New York to present to investors at Proactive's CannaJam Forum. Hill says he believes US and Canadian investors alike are very excited about the cannabis space, and says while the US is a tantalizing market, Emerald is watching carefully how regulations around marijuana legalization changes before making any moves into the states. In Canada, Emerald Health has recently confirmed a cannabis supply agreement Ontario Cannabis Retail Corporation in anticipation of the adult-use market starting October 17, 2018.
Peninsula Energy to become globally competitive uranium producer with low-pH ISR operation
 
06:41
Peninsula Energy Ltd (ASX:PEN) managing director & CEO Wayne Heili and non-executive chairman John Harrison update Proactive Investors on the uranium company’s recently completed feasibility study for its Lance Project in Wyoming, which supports the project’s transformation to a low-pH in-situ recovery (IRS) uranium operation. The study shows that Peninsula would become a globally competitive uranium producer by switching its uranium production method to low-pH ISR. “This is a low-risk, high-opportunity company,” Harrison says. He continues, “we have the ability to continue producing uranium in the manner that we are. We also have the ability – when we have the regulatory permits – to change it to a low-pH project which will only cost $5 million to convert the existing mine.”
Data443 Risk Mitigation's tech allows Facebook users to find own personal data on accounts
 
05:57
Data443 Risk Mitigation Inc (OTCMKTS:LDSR) CEO Jason Remillard had a chat with Proactive Investors at the MicroCap Conference in New York. The North Carolina-based software company, formerly known as LandStar Inc, develops cybersecurity products and services.
Echo Energy's Fiona MacAulay delighted with Argentina exploration programme
 
14:45
Echo Energy PLC's (LON:ECHO) Fiona MacAulay spoke to Proactive's Andrew Scott following the completion of their four-well programme in Argentina. ''To have encountered hydrocarbons in each of those four wells has been very exciting for me and specifically for the team''. MacAulay says they're now looking forward to the beginning of testing on the ELM 1004 well - the first well to be tested in this programme.
Falcon Oil & Gas 'taking Beetaloo shale project forward at pace'
 
08:59
Philip O'Quigley, chief executive of Falcon Oil & Gas Ltd (LON:FOG, CVE:FO) tells Proactive's Andrew Scott that they, along with their partner Origin Energy, have agreed to accelerate exploration activity for the Beetaloo shale project. Together they now deem the Stage 1 campaign to be complete, essentially meaning that in light of the 2014 successes – drilling three vertical wells and one horizontal, fracture stimulated well – that it is now appropriate to move ahead. In all, the Stage 2 cost cap is now A$65mln. Any portion of the additional budget not spent in Stage 2 will carry over into Stage 3 (which presently has a cap of A$48mln). ''This is a huge step forward now'' ''The moratorium is gone, the recommendations are being implemented by the government ... working with industry... and we're now taking this forward at pace''. ''This is a huge step forward for the Beetaloo Basin, for Falcon and for Origin ... it's a good day''.
Rig mobilised to Europa Metals' Toral project ahead of Phase One drilling
 
11:31
Laurence Read, executive director of Europa Metals Limited (LON:EUZ), tells Proactive's Andrew Scott they've mobilised a rig at the Toral project in northern Spain as they prepare to begin a campaign to evaluate the potential extension of the mineral structure. Read says phase one of the programme will involve drilling to determine whether a mineralised structure at the project continues outside the current defined JORC resource area for the project.
Montana Exploration's acreage hosts a "fairway for oil exploration" within Shaunavon oil trend
 
08:08
Charles Selby, Chairman and Chief Executive Officer of Montana Exploration Corp. (TSX-V:MTZ), tells ProactiveInvestors about the company's "substantial land base" in Montana, which partly overlaps the Shaunavon oil play. Charles discusses the company's recent 54 Sq. Mile 3D Seismic Survey, indicating "multiple drilling targets" in many potential locations. Charles also says that the company's plans going forward will include "looking at many other opportunities" including "oil-prone, scalable, relatively low risk" assets.
Sirius Minerals PLC chief discusses DFS and York Potash financing
 
06:41
The long-awaited definitive feasibility study (DFS) for Sirius Minerals PLC's (LON:SXX) York Potash Project in North Yorkshire has underscored its huge potential. The report says its net present value today is US$15bn using a 10% discount rate. Managing Director, Chris Fraser, tells Proactive that the firm is “ready to go” on construction of the project, with the company now looking to how it will finance its development. He adds that the projects biggest competitive advantage is its margins, with the company expecting “around 70% margins up to 85% - and it’s very difficult to find projects or companies that come even close to those margins.”
PreveCeutical Medical strikes deal with Asterion Cannabis for medical CBD
 
07:21
Stephen Van Deventer, chairman and CEO of PreveCeutical Medical Inc (CNSX:PREV), discusses with Proactive's Andrew Scott the deal they've struck with private firm Asterion Cannabis Inc to develop medical CBD (cannabidiol) products. In the companies’ sights via the joint venture are tablets, transdermal patches and other jointly evaluated products aimed at treating chronic pain, inflammation, epilepsy, anxiety disorders and others.
Arc Minerals reports strong results from early drilling at Kalaba in Zambia
 
05:17
Nick von Schirnding, executive chairman of Arc Minerals LTD (LON:ARCM), tells Proactive's Andrew Scott they've intersected extensive copper and cobalt mineralisation in drilling at the Kalaba prospect in Zambia, which is part of the larger Zamsort project. All four of the reverse circulation holes drilled intersected copper and cobalt mineralisation. Among the highlights were 20 metres at 1.31% copper equivalent, 25m at 1.24% copper equivalent, and 26 metres at 1.10% copper equivalent. In addition, 19 diamond drill holes have been completed with initial assays expected shortly.
Premier Oil PLC in a strong position to generate significant free cash flow
 
14:26
Tony Durrant, chief executive of Premier Oil PLC (LON:PMO), runs Proactive's Andrew Scott through their portfolio of production and exploration assets as well as plans for further acquisitions in the UK North Sea. ''We're at 85,000 barrels a day - most of that comes from the UK''. ''We've been investing significantly in the UK North Sea over the last few years ... of course the industry has gone through a difficult period with low oil prices, we've continued to invest in that period - specifically we've pushed ahead with our Catcher project in the North Sea''.
First Mining Gold provides update on flagship project while selling another!
 
05:45
First Mining Gold (CVE:FF) Vice President of Investor Relations Derek Iwanaka stopped by Proactive Investors Vancouver to talk about the company and their many diversified projects in Canada, the U.S. and Mexico. Iwanaka also updated their flagship project in Ontario and also had details of a sale of another one of their projects in Mexico.
Argo Blockchain Plc becomes London's first cryptocurrency listing
 
05:43
Jonathan Bixby, executive chairman of Argo Blockchain Plc (LON:ARB) caught up with Proactive's Andrew Scott as they became the first crypto-mining company to join London's stock market. Argo raised £25mln as institutions and influential high net worth backers got behind the company’s mining as a service (MaaS) business model. On the shareholder register are Miton Capital, Henderson Global Investors and Jupiter Asset Management, while Bixby and co-founder Mike Edwards own around 13% of the company. ''The London market really wanted to hear our story'', Bixby says. ''They were very receptive to it and we've got some quality, long-term investors on board which I'm really excited about''.
Echo Energy's VP of Exploration 'very encouraged' by recent Argentina drilling
 
14:44
Julian Besser, Echo Energy Plc's (LON:ECHO) VP of Exploration, discusses with Proactive's Andrew Scott their recent exploration campaign in Argentina. ''The first half of this year's been focusing on the east of the Austral basin … we've got acreage in both the west and east … and one of the key questions we had about the east was how much growth potential do we have, what's the running room … so that's what this exploration campaign was addressing''. ''We've got two reservoirs … and we were testing those on both an oil fairway and a gas migration fairway, so that gives rise to our four plays and each of those wells were testing those plays''.
Zelda enters rapidly-growing German market with product commercialisation strategy
 
04:50
Zelda Therapeutics Ltd (ASX:ZLD) founder and executive chairman Harry Karelis updates Proactive Investors on the cannabis company’s progress with clinical trials as well as its recent entry into the German market. Zelda has entered a distribution and manufacturing strategic partnership with German medicinal cannabis group HAPA Medical. As per the deal, HAPA will have first rights to distribute and/or manufacture Zelda’s clinically validated formulations into the rapidly growing German market. With a population of 83 million people, Germany is estimated to have the potential to become the world’s largest single medical cannabis market.
Sethi Petroleum optimistic about 2014
 
04:30
Sameer Sethi, CEO of Sethi Petroleum LLC, a company that invests in early stage oil & gas companies, tells Proactive Investors that he is "excited about the horizon" and that 2014 will bring "ten times more funding".
ValiRx Plc enjoying strong industry interest in its cancer treatments
 
10:10
George Morris, chief operations officer at ValiRx Plc (LON:VAL), updates Proactive's Andrew Scott on developments across the company's portfolio. Morris says advanced conversations are continuing with possible partners as they look to press ahead with the development of their flagship VAL401 lung cancer candidate.
The Market Maker; what they do and how they make a market
 
10:17
ishareinfo.tv, in association with Proactiveinvestors, speaks to a market maker about pricing, the practice of going long and short on a stock and the effects of economic data and company news on the direction of shares.
Recent cannabis stock volatility not dampening industry prospects
 
07:03
Proactive Investor contributor Bob Byrne looks at the recent rise and fall of Tilray Inc (NASDAQ:TLRY). Byrne says while Constellation Brands may be responsible for the initial bout of bullish momentum that’s fueled the recent rise in cannabis stocks, it was last week’s volatility in shares of Canadian marijuana producer Tilray Inc (Nasdaq:TLRY) that set the industry alight.

fhm dating offer code
free online dating sites china
dating ring co founders
matchmaking sites
dating rules second date